lifestyle.xbode.org

Author: Immunocore Holdings plc

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma

April 19, 2026
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference

April 6, 2026
Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting

March 17, 2026
Immunocore to present at upcoming investor conferences

March 3, 2026
Immunocore reports fourth quarter and full year 2025 financial results and provides a business update

February 25, 2026
Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025

February 18, 2026
Immunocore announces R&D leadership evolution

January 30, 2026